L. Bankir, M. Ahloulay, N. Bouby, M. M. Trinh-trang-tan, F. Machet et al., Is the process of urinary urea concentration responsible for a high glomerular filtration rate?, J Am Soc Nephrol, vol.4, pp.1091-103, 1993.

L. Bankir, N. Bouby, and E. Ritz, Vasopressin: a novel target for the prevention and retardation of kidney disease?, Nature Reviews Nephrology, vol.60, issue.4, pp.223-239, 2013.
DOI : 10.1046/j.1523-1755.2001.060002748.x

P. Bardoux, D. G. Bichet, H. Martin, Y. Gallois, M. Marre et al., Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system, Nephrology Dialysis Transplantation, vol.18, issue.3, 2003.
DOI : 10.1093/ndt/18.3.497

P. Bardoux, P. Bruneval, D. Heudes, N. Bouby, and L. Bankir, Diabetes-induced albuminuria: role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats, Nephrology Dialysis Transplantation, vol.18, issue.9, pp.1755-1763, 2003.
DOI : 10.1093/ndt/gfg277

B. Betz and B. R. Conway, Recent Advances in Animal Models of Diabetic Nephropathy, Nephron Experimental Nephrology, vol.126, issue.4, pp.191-196, 2014.
DOI : 10.1159/000363300

P. Bjornstad, D. M. Maahs, T. Jensen, M. A. Lanaspa, R. J. Johnson et al., Elevated copeptin is associated with atherosclerosis and diabetic kidney disease in adults with type 1 diabetes, Journal of Diabetes and its Complications, vol.30, issue.6, pp.1093-1099, 2016.
DOI : 10.1016/j.jdiacomp.2016.04.012

W. E. Boertien, I. J. Riphagen, I. Drion, A. Alkhalaf, S. J. Bakker et al., Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33), Diabetologia, vol.14, issue.8, pp.1680-1688, 2013.
DOI : 10.1001/archinte.1962.03620230204028

N. Bouby, S. Bachmann, D. Bichet, and L. Bankir, Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat, Am J Physiol, vol.258, pp.973-979, 1990.

B. Cantau, G. Guillon, M. N. Mathieu, D. Vidal-chicot, and C. Chevillard, Reduction in hepatic but not in renal and vascular vasopressin receptor number in hyperinsulinemic mice and rats, Molecular and Cellular Endocrinology, vol.38, issue.2-3, pp.131-140, 1984.
DOI : 10.1016/0303-7207(84)90111-4

S. Enhorning, L. Bankir, N. Bouby, J. Struck, B. Hedblad et al., Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malm?? Diet and Cancer Study cardiovascular cohort, International Journal of Obesity, vol.212, issue.4, pp.598-603, 2013.
DOI : 10.1038/ki.2009.267

W. Hu, Y. J. Ni, L. Ma, H. R. Hao, L. Chen et al., Serum copeptin as a new biomarker in the early diagnosis of decline in renal function of type 2 diabetes mellitus patients, Int J Clin Exp Med, vol.8, pp.9730-9736, 2015.

D. Z. Levine, M. Iacovitti, and S. J. Robertson, Modulation of single-nephron GFR in the db/db mouse model of type 2 diabetes mellitus. II. Effects of renal mass reduction, AJP: Regulatory, Integrative and Comparative Physiology, vol.294, issue.6, pp.1840-1846, 2008.
DOI : 10.1152/ajpregu.00457.2007

M. Morita, Y. Kita, N. Morikawa, M. Iwami, and Y. Notsu, receptor mRNA in diabetic (db/db) mice, Experimental and Clinical Endocrinology & Diabetes, vol.109, issue.05, pp.261-267, 2001.
DOI : 10.1055/s-2001-16345

M. Pikkemaat, O. Melander, and K. Bengtsson-bostrom, Association between copeptin and declining glomerular filtration rate in people with newly diagnosed diabetes. The Skaraborg Diabetes Register, Journal of Diabetes and its Complications, vol.29, issue.8, pp.1062-1065, 2015.
DOI : 10.1016/j.jdiacomp.2015.07.006

A. T. Reutens, Epidemiology of Diabetic Kidney Disease, Medical Clinics of North America, vol.97, issue.1, pp.1-18, 2013.
DOI : 10.1016/j.mcna.2012.10.001

R. Roussel, N. Matallah, N. Bouby, R. Boustany, L. Potier et al., Plasma Copeptin and Decline in Renal Function in a Cohort from the Community: The Prospective D, E.S.I.R. Study. Am J Nephrol, vol.42, pp.107-114, 2015.

C. Taveau, C. Chollet, L. Waeckel, D. Desposito, D. G. Bichet et al., Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats, Diabetologia, vol.48, issue.5, pp.1081-1090, 2015.
DOI : 10.1002/hep.22467

G. Velho, N. Bouby, S. Hadjadj, N. Matallah, K. Mohammedi et al., Plasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria, Diabetes Care, vol.36, issue.11, pp.3639-3645, 2013.
DOI : 10.2337/dc13-0683
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816878

G. Velho, R. Boustany, G. Lefevre, K. Mohammedi, F. Fumeron et al., Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes, Diabetes Care, vol.39, issue.12, pp.2288-2295, 2016.
DOI : 10.2337/dc16-1003

F. X. Zhu, H. L. Wu, K. S. Tu, J. X. Chen, M. Zhang et al., Serum levels of copeptin are associated with type 2 diabetes and diabetic complications in Chinese population, Journal of Diabetes and its Complications, vol.30, issue.8, pp.1566-1570, 2016.
DOI : 10.1016/j.jdiacomp.2016.07.017